Skip to main content

Table 2 Revascularization and drug therapy during follow-up

From: Multivessel coronary artery disease, free fatty acids, oxidized LDL and its antibody in myocardial infarction

Therapy, n (%)

All patients (n = 400)

β-blockers

358 (89.5)

Angiotensin-convertingenzyme

328 (82.1)

Calcium channel blocker

278 (69.5)

Diuretics

168 (42)

Nitrates

350 (87.4)

Aspirin

351 (87.8)

Heparin

400 (100)

Clopidogrel

314 (78.5)

Statins

400 (100)

Thrombolysis

24 (6.1)

Percutaneous coronary intervention

196 (49.1)